When selecting a Press Release of the Month, Medianet recognises standout communications that deliver impact, credibility, and strategic resonance - and Monash University’s announcement on an anti-nausea drug’s potential in improving breast cancer survival rates fits the bill perfectly. Here are some reasons why it was picked:
1. Breakthrough health discovery with strong human impact
Monash revealed that a common anti-nausea drug, aprepitant, is linked with an 11 % reduction in recurrence and 17 % lower risk of death, with even more dramatic benefits (34 – 39%) for women diagnosed with triple-negative breast cancer, one of the most aggressive subtypes. This kind of high-impact, human-centred result (News value: impact) is gold for media coverage and social amplification.
2. Credible, large-scale data set
The findings were drawn from a multi-country clinical data set involving 13,811 Norwegian patients over 12 years, published in the prestigious Journal of the National Cancer Institute (News value: prominence). Backed by peer-reviewed science and global collaboration, it provided journalists with a strong, citable story.
3. Repositioning a familiar drug uniquely
Monash deftly repositioned aprepitant - previously seen merely as an anti-nausea drug - as a potential adjuvant cancer therapy (News value: novelty). This has major PR appeal: fresh insights from known products drive real interest from outlets and experts alike.(News value: relevance/currency)
4. Strategic narrative & future outlook
The release didn’t just present data - it framed the discovery with statements from senior researchers (Dr Aeson Chang, Professor Erica Sloan), emphasising accelerated paths to clinical trials and guideline updates. It set up a compelling “what’s next” storyline that spurs journalists and stakeholders to stay tuned (News value: timeliness).
5. Broad relevance and multiple media angles
The release secured wide national and international exposure across trusted outlets. This story appeals across industries- from health and science to women’s issues and pharma - making it attractive to diverse media outlets. That multidimensional relevance lead to national coverage and sustained media engagement.
Medianet’s pick confirms that PR excellence lies in blending scientific rigour, human relevance, and clear strategic framing - all delivered through compelling storytelling.
Want to amplify your organisation’s PR strategy? Contact Medianet today.
Share
Top